Detection and structural characterization of insulin prefibrilar oligomers using surface enhanced Raman spectroscopy

Biotechnology Progress

Volumn 30, Issue 2, 2014, Pages 488-495

  Kurouski, Dmitry ^a   Sorci, Mirco ^b   Postiglione, Thomas ^a   Belfort, Georges ^b   Lednev, Igor K ^a  

^a STATE UNIVERSITY OF NEW YORK   (United States)

^b Rensselaer Polytechnic Institute   (United States)

Author keywords

Amyloid fibrils; DUVRR; Insulin; Oligomers; SERS

Indexed keywords

AGGREGATES; CHARACTERIZATION; GLYCOPROTEINS; INSULIN; MOLECULES; RAMAN SPECTROSCOPY;

AMYLOID FIBRIL; DUVRR; SERS; SINGLE MOLECULE LEVEL; STRUCTURAL CHARACTERIZATION; STRUCTURAL ORGANIZATION; STRUCTURE AND MORPHOLOGY; SURFACE ENHANCED RAMAN SPECTROSCOPY;

OLIGOMERS;

INSULIN; PROTEIN AGGREGATE; RECOMBINANT PROTEIN;

CHEMISTRY; HUMAN; PROCEDURES; RAMAN SPECTROMETRY; ULTRAVIOLET SPECTROPHOTOMETRY;

HUMANS; INSULIN; PROTEIN AGGREGATES; RECOMBINANT PROTEINS; SPECTROPHOTOMETRY, ULTRAVIOLET; SPECTRUM ANALYSIS, RAMAN;

EID: 84898543718     PISSN: 87567938     EISSN: 15206033     Source Type: Journal    
DOI: 10.1002/btpr.1852     Document Type: Article

References (60)

1. Dobson CM. Protein folding and misfolding. Nature. 2003;426:884-890.
2. Sipe JD. Amyloid Proteins The Beta Sheet Conformation and Disease. New York: Wiley, 2005.
3. Munch J, Rucker E, Standker L, Adermann K, Goffinet C, Schindler M, Wildum S, Chinnadurai R, Rajan D, Specht A, Gimenez-Gallego G, Sanchez PC, Fowler DM, Koulov A, Kelly JW, Mothes W, Grivel JC, Margolis L, Keppler OT, Forssmann WG, Kirchhoff F. Semen-derived amyloid fibrils drastically enhance HIV infection. Cell. 2007;131:1059-1071.
4. Kisilevsky R. Review: amyloidogenesis-unquestioned answers and unanswered questions. J Struct Biol. 2000;130:99-108.
5. Kay CJ. Mechanochemical mechanism for peptidyl free radical generation by amyloid fibrils. FEBS Lett. 1997;403:230-235.
6. Pogocki D. Alzheimer's beta-amyloid peptide as a source of neurotoxic free radicals: the role of structural effects. Acta Neurobiol Exp. 2003;63:131-145.
7. Friedrich RP, Tepper K, Ronicke R, Soom M, Westermann M, Reymann K, Kaether C, Fandrich M. Mechanism of amyloid plaque formation suggests an intracellular basis of Abeta pathogenicity. Proc Natl Acad Sci USA. 107:1942-1947.
8. LaFerla FM, Green KN, Oddo S. Intracellular amyloid-beta in Alzheimer's disease. Nat Rev Neurosci. 2007;8:499-509.
9. Lindquist SL, Kelly JW. Chemical and biological approaches for adapting proteostasis to ameliorate protein misfolding and aggregation diseases: progress and prognosis. Cold Spring Harb Perspect Biol. 2011;3:a004507.
10. Cohen SI, Linse S, Luheshi LM, Hellstrand E, White DA, Rajah L, Otzen DE, Vendruscolo M, Dobson CM, Knowles TP. Proliferation of amyloid-beta42 aggregates occurs through a secondary nucleation mechanism. Proc Natl Acad Sci USA. 2013;110:9758-9763.
11. Murphy RM, Roberts CJ. Protein misfolding and aggregation research: some thoughts on improving quality and utility. Biotechnol Prog. 2013;29:1109-1115.
12. Kurouski D, Deckert-Gaudig T, Deckert V, Lednev IK. Structure and composition of insulin fibril surfaces probed by TERS. J Am Chem Soc. 2012;134:13323-13329.
13. Ivanova MI, Sievers SA, Sawaya MR, Wall JS, Eisenberg D. Molecular basis for insulin fibril assembly. Proc Natl Acad Sci USA. 2009;106:18990-18995.
14. Nayak A, Sorci M, Krueger S, Belfort G. A universal pathway for amyloid nucleus and precursor formation for insulin. Proteins. 2009;74:556-565.
15. Sorci M, Grassucci RA, Hahn I, Frank J, Belfort G. Time-dependent insulin oligomer reaction pathway prior to fibril formation: cooling and seeding. Proteins. 2009;77:62-73.
16. Vestergaard B, Groenning M, Roessle M, Kastrup JS, van de Weert M, Flink JM, Frokjaer S, Gajhede M, Svergun DI. A helical structural nucleus is the primary elongating unit of insulin amyloid fibrils. PLoS Biol. 2007;5:e134.
17. Nettleton EJ, Tito P, Sunde M, Bouchard M, Dobson CM, Robinson CV. Characterization of the oligomeric states of insulin in self-assembly and amyloid fibril formation by mass spectrometry. Biophys J. 2000;79:1053-1065.
18. Pease LF 3-rd, Sorci M, Guha S, Tsai DH, Zachariah MR, Tarlov MJ, Belfort G. Probing the nucleus model for oligomer formation during insulin amyloid fibrillogenesis. Biophys J. 2010;99:3979-3985.
19. Kim JR, Gibson TJ, Murphy RM. Targeted control of kinetics of beta-amyloid self-association by surface tension-modifying peptides. J Biol Chem. 2003;278:40730-40735.
20. Sorci M, Silkworth W, Gehan T, Belfort G. Evaluating nuclei concentration in amyloid fibrillation reactions using back-calculation approach. PLoS One. 2011;6:e20072.
21. Kneipp J, Kneipp H, Kneipp K. SERS-a single-molecule and nanoscale tool for bioanalytics. Chem Soc Rev. 2008;37:1052-1060.
22. Hering K, Cialla D, Ackermann K, Dorfer T, Moller R, Schneidewind H, Mattheis R, Fritzsche W, Rosch P, Popp J. SERS: a versatile tool in chemical and biochemical diagnostics. Anal Bioanal Chem. 2008;390:113-124.
23. Kleinman SL, Sharma B, Blaber MG, Henry AI, Valley N, Freeman RG, Natan MJ, Schatz GC, Van Duyne RP. Structure enhancement factor relationships in single gold nanoantennas by surface-enhanced Raman excitation spectroscopy. J Am Chem Soc. 2012;135:301-308.
24. Sagle LB, Ruvuna LK, Ruemmele JA, Van Duyne RP. Advances in localized surface plasmon resonance spectroscopy biosensing. Nanomedicine. 2011;6:1447-1462.
25. Kurouski D, Postiglione T, Deckert-Gaudig T, Deckert V, Lednev IK. Amide I vibrational mode suppression in surface (SERS) and tip (TERS) enhanced Raman spectra of protein specimens. Analyst. 2013;138:1665-1673.
26. Kurouski D, Washington J, Ozbil M, Prabhakar R, Shekhtman A, Lednev IK. Disulfide bridges remain intact while native insulin converts into amyloid fibrils. Plos One. 2012;7:e36989.
27. Han XX, Zhao B, Ozaki Y. Surface-enhanced Raman scattering for protein detection. Anal Bioanal Chem. 2009;394:1719-1727.
28. Dinish US, Fu CY, Soh KS, Ramaswamy B, Kumar A, Olivo M. Highly sensitive SERS detection of cancer proteins in low sample volume using hollow core photonic crystal fiber. Biosens Bioelectron. 2012;33:293-298.
29. Chou IH, Benford M, Beier HT, Cote GL, Wang M, Jing N, Kameoka J, Good TA. Nanofluidic biosensing for beta-amyloid detection using surface enhanced Raman spectroscopy. Nano Lett. 2008;8:1729-1735.
30. Jansen R, Dzwolak W, Winter R. Amyloidogenic self-assembly of insulin aggregates probed by high resolution atomic force microscopy. Biophys J. 2005;88:1344-1353.
31. Lednev IK. Vibrational spectroscopy: biological applications of ultraviolet Raman spectroscopy. In: Uversky VN, Permyakov EA. Protein Structures, Methods in Protein Structures and Stability Analysis. New York: Nova Science 2007:1-26.
32. Oladepo SA, Xiong K, Hong Z, Asher SA, Handen J, Lednev IK. UV Resonance Raman Investigations of Peptide and Protein Structure and Dynamics. Chem Rev. 2012;112:2604-2628.
33. Shashilov V, Xu M, Ermolenkov VV, Fredriksen L, Lednev IK. Probing a fibrillation nucleus directly by deep ultraviolet Raman spectroscopy. J Am Chem Soc. 2007;129:6972-6973.
34. Stiles PL, Dieringer JA, Shah NC, Van Duyne RP. Surface-enhanced Raman spectroscopy. Annu Rev Anal Chem. 2008;1:601-626.
35. Deckert-Gaudig T, Deckert V. Tip-enhanced Raman scattering studies of histidine on novel silver substrates. J Raman Spectrosc. 2009;40:1446-1451.
36. Carey PR. Biochemical Applications of Raman and Resonance Raman Spectroscopies. New York: Academic Press; 1982.
37. Fabian H, Anzenbacher P. New developments in Raman spectroscopy of biological systems. Vibrat Spectrosc. 1993;4:125-148.
38. Dong J, Wan Z, Popov M, Carey PR, Weiss MA. Insulin assembly damps conformational fluctuations: Raman analysis of amide I linewidths in native states and fibrils. J Mol Biol. 2003;330:431-442.
39. Matsuo K, Yonehara R, Gekko K. Improved estimation of the secondary structures of proteins by vacuum-ultraviolet circular dichroism spectroscopy. J Biochem. 2005;138:79-88.
40. Sethuraman A, Han M, Kane RS, Belfort G. Effect of surface wettability on the adhesion of proteins. Langmuir. 2004;20:7779-7788.
41. Anand G, Zhang F, Linhardt RJ, Belfort G. Protein-associated water and secondary structure effect removal of blood proteins from metallic substrates. Langmuir. 2011;27:1830-1836.
42. Lee CC, Nayak A, Sethuraman A, Belfort G, McRae GJ. A three-stage kinetic model of amyloid fibrillation. Biophys J. 2007;92:3448-3458.
43. Hudson SA, Ecroyd H, Kee TW, Carver JA. The thioflavin T fluorescence assay for amyloid fibril detection can be biased by the presence of exogenous compounds. FEBS J. 2009;276:5960-5972.
44. Nielsen L, Khurana R, Coats A, Frokjaer S, Brange J, Vyas S, Uversky VN, Fink AL. Effect of environmental factors on the kinetics of insulin fibril formation: elucidation of the molecular mechanism. Biochemistry. 2001;40:6036-6046.
45. Biancalana M, Koide S. Molecular mechanism of Thioflavin-T binding to amyloid fibrils. Biochim Biophys Acta. 2010;1804:1405-1412.
46. Shankar GM, Li S, Mehta TH, Garcia-Munoz A, Shepardson NE, Smith I, Brett FM, Farrell MA, Rowan MJ, Lemere CA, Regan CM, Walsh DM, Sabatini BL, Selkoe DJ. Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nat Med. 2008;14:837-842.
47. Groenning M, Frokjaer S, Vestergaard B. Formation mechanism of insulin fibrils and structural aspects of the insulin fibrillation process. Curr Protein Pept Sci. 2009;10:509-528.
48. Dobson CM. Protein aggregation and its consequences for human disease. Prot Pept Lett. 2006;13:219-227.
49. Wang Y, Srinivasan S, Ye Z, Javier Aguilera J, Lopez MM, Colon W. Serum amyloid A 2.2 refolds into a octameric oligomer that slowly converts to a more stable hexamer. Biochem Biophys Res Commun. 2011;407:725-729.
50. Ladiwala AR, Lin JC, Bale SS, Marcelino-Cruz AM, Bhattacharya M, Dordick JS, Tessier PM. Resveratrol selectively remodels soluble oligomers and fibrils of amyloid Abeta into off-pathway conformers. J Biol Chem. 2010;285:24228-24237.
51. Xu M, Ermolenkov VV, Uversky VN, Lednev IK. Hen egg white lysozyme fibrillation: a deep-UV resonance Raman spectroscopic study. J Biophoton. 2008;1:215-229.
52. Xu M, Shashilov VA, Ermolenkov VV, Fredriksen L, Zagorevski D, Lednev IK. The first step of hen egg white lysozyme fibrillation, irreversible partial unfolding, is a two-state transition. Protein Sci. 2007;16: 815-832.
53. Zako T, Sakono M, Hashimoto N, Ihara M, Maeda M. Bovine insulin filaments induced by reducing disulfide bonds show a different morphology, secondary structure, and cell toxicity from intact insulin amyloid fibrils. Biophys J. 2009;96:3331-3340.
54. Aitken JF, Loomes KM, Konarkowska B, Cooper GJ. Suppression by polycyclic compounds of the conversion of human amylin into insoluble amyloid. Biochem J. 2003;374:779-784.
55. Gazit E. Mechanisms of amyloid fibril self-assembly and inhibition. Model short peptides as a key research tool. FEBS J. 2005;272:5971-5978.
56. Kayed R, Head E, Sarsoza F, Saing T, Cotman CW, Necula M, Margol L, Wu J, Breydo L, Thompson JL, Rasool S, Gurlo T, Butler P, Glabe CG. Fibril specific, conformation dependent antibodies recognize a generic epitope common to amyloid fibrils and fibrillar oligomers that is absent in prefibrillar oligomers. Mol Neurodegener. 2007;2:18.
57. Kayed R, Head E, Thompson JL, McIntire TM, Milton SC, Cotman CW, Glabe CG. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science. 2003;300:486-489.
58. Glabe CG. Structural classification of toxic amyloid oligomers. J Biol Chem. 2008;283:29639-29643.
59. rd, Pensalfini A, Yeung S, Head E, Marsh JL, Glabe C. Conformation dependent monoclonal antibodies distinguish different replicating strains or conformers of prefibrillar Abeta oligomers. Mol Neurodegener. 2010;5:57.
60. Wu JW, Breydo L, Isas JM, Lee J, Kuznetsov YG, Langen R, Glabe C. Fibrillar oligomers nucleate the oligomerization of monomeric amyloid beta but do not seed fibril formation. J Biol Chem. 2010;285:6071-6079.